Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€1.32

€1.32

5.640%
0.072
5.640%
-
 
17.04.24 / Tradegate WKN: A2PU3T / Symbol: RXII / Name: SELLAS Life Sciences / Stock / Pharmaceuticals / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

SELLAS Life Sciences Group Inc Stock

SELLAS Life Sciences Group Inc dominated the market today, gaining €0.072 (5.640%).
For the coming years our community has positive and negative things to say abot the SELLAS Life Sciences Group Inc stock. Criterium "Management" gathered the most positive votes but regarding "Innovation" there were negative voices in the community.

SELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.

Pros and Cons of SELLAS Life Sciences Group Inc in the next few years

Pros
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of SELLAS Life Sciences Group Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
SELLAS Life Sciences Group Inc 5.640% 2.171% 27.961% -9.478% 35.179% -78.962% -99.641%
Beximco Pharmaceuticals Ltd. GDR - 0.000% -3.670% -16.000% -4.545% -57.360% -22.222%
Cellectar BioSciences Inc. -3.850% -7.362% -5.031% 139.683% 32.456% -74.833% -
Arca Biopharma -2.600% 3.448% 91.693% 61.725% 92.926% 7.143% -94.709%